POP QUIZ: Tirzepatide for weight managementTirzepatide injection (Zepbound KwikPen) is now available in Canada for chronic weight management. Study finds ADHD medication associated with reduced risks of suicide and criminal behaviourA large Swedish study published in the BMJ found methylphenidate is associated with a significant reduction in suicidal behavior, substance use, transport accidents and crime. U.S. FDA approves another generic abortion pill, prompting outrage from conservatives U.S. officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration. Tapinarof topical cream (Nduvra) is now available for the treatment of psoriasis First aryl hydrocarbon receptor agonist results in downregulation of proinflammatory cytokines, skin-barrier normalization and antioxidant activity. 5 pearls: pharmacist prescribing, optimized Examine your workflow and see where pharmacists’ time can be freed up and refocused into caring for patients and providing prescribing services. Drug News—September 2025 A review of new launches, new indications, new dosage forms and Health Canada advisories. Geriatrics and pharmacology: A new guide to Beer Criteria alternatives A new resource offers alternatives to options on the Beers Criteria list for use when deprescribing for elderly patients. 10 new drug indications pharmacists and physicians need to know about Get the info you need on these new drug indications, part of our drug news roundup for September. Three new dosage forms physicians and pharmacists need to know about Get the info you need on these new dosage forms, part of our drug news roundup for September. Three new drugs pharmacists and physicians need to know about (plus three new generics) Get the info you need on these new drugs, part of our drug news roundup for September. First Previous 4 5 6 7 8 Next Last
